Shop

The Wall Street Journal looks at the role of Cipla Ltd., an Indian pharmaceuticals company, in the "extraordinary price war for supplying the lifesaving medicines to Africa and developing nations elsewhere." The story reveals that Cipla has offered "to sell a triple combination of "antiretroviral" AIDS drugs to the international aid group Doctors Without Borders at less than $1 a day per patient..." The reporter finds that even though "multinational pharmaceuticals companies dismiss Cipla and its peers as "patent" pirates," the smaller rivals are "transforming the debate over how to provide critical medicines to poor nations."

This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org